vs
GE医疗（DHC）与Rapid7, Inc.（RPD）财务数据对比。点击上方公司名可切换其他公司
GE医疗的季度营收约是Rapid7, Inc.的1.7倍（$379.6M vs $217.4M），Rapid7, Inc.净利率更高（1.4% vs -5.6%，领先7.0%），Rapid7, Inc.同比增速更快（0.5% vs -0.0%），Rapid7, Inc.自由现金流更多（$36.4M vs $-166.4M），过去两年Rapid7, Inc.的营收复合增速更高（3.0% vs 1.2%）
GE医疗是一家总部位于美国伊利诺伊州芝加哥市的医疗科技企业，业务涵盖四大板块：医疗影像设备，包括分子成像、CT、核磁共振、妇科健康筛查及X光系统；超声设备；患者护理解决方案，聚焦远程患者监测、麻醉呼吸护理、心脏诊断及婴幼儿护理；此外还涉及医药相关领域，是全球医疗行业的知名企业。
Rapid7是全球领先的网络安全企业，提供漏洞管理、威胁检测与响应、云安全、安全分析等全系列安全解决方案，服务全球科技、医疗、金融、制造等行业的各类规模企业及公共部门客户，助力客户高效识别、应对和缓解网络安全风险。
DHC vs RPD — 直观对比
营收规模更大
DHC
是对方的1.7倍
$217.4M
营收增速更快
RPD
高出0.5%
-0.0%
净利率更高
RPD
高出7.0%
-5.6%
自由现金流更多
RPD
多$202.9M
$-166.4M
两年增速更快
RPD
近两年复合增速
1.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $379.6M | $217.4M |
| 净利润 | $-21.2M | $3.1M |
| 毛利率 | — | 68.9% |
| 营业利润率 | -12.6% | 1.0% |
| 净利率 | -5.6% | 1.4% |
| 营收同比 | -0.0% | 0.5% |
| 净利润同比 | 75.7% | 44.1% |
| 每股收益（稀释后） | $-0.09 | $0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DHCRPD
| Q4 25 | $379.6M | $217.4M | ||
| Q3 25 | $388.7M | $218.0M | ||
| Q2 25 | $382.7M | $214.2M | ||
| Q1 25 | $386.9M | $210.3M | ||
| Q4 24 | $379.6M | $216.3M | ||
| Q3 24 | $373.6M | $214.7M | ||
| Q2 24 | $371.4M | $208.0M | ||
| Q1 24 | $370.8M | $205.1M |
净利润DHCRPD
| Q4 25 | $-21.2M | $3.1M | ||
| Q3 25 | $-164.0M | $9.8M | ||
| Q2 25 | $-91.6M | $8.3M | ||
| Q1 25 | $-9.0M | $2.1M | ||
| Q4 24 | $-87.4M | $2.2M | ||
| Q3 24 | $-98.7M | $15.4M | ||
| Q2 24 | $-97.9M | $6.5M | ||
| Q1 24 | $-86.3M | $1.4M |
毛利率DHCRPD
| Q4 25 | — | 68.9% | ||
| Q3 25 | — | 70.2% | ||
| Q2 25 | — | 70.6% | ||
| Q1 25 | — | 71.7% | ||
| Q4 24 | — | 69.5% | ||
| Q3 24 | — | 70.6% | ||
| Q2 24 | — | 70.7% | ||
| Q1 24 | — | 70.3% |
营业利润率DHCRPD
| Q4 25 | -12.6% | 1.0% | ||
| Q3 25 | -43.4% | 2.7% | ||
| Q2 25 | -24.5% | 1.6% | ||
| Q1 25 | -2.7% | -0.0% | ||
| Q4 24 | -26.1% | 3.4% | ||
| Q3 24 | -26.5% | 6.0% | ||
| Q2 24 | -23.0% | 2.5% | ||
| Q1 24 | -23.7% | 4.7% |
净利率DHCRPD
| Q4 25 | -5.6% | 1.4% | ||
| Q3 25 | -42.2% | 4.5% | ||
| Q2 25 | -23.9% | 3.9% | ||
| Q1 25 | -2.3% | 1.0% | ||
| Q4 24 | -23.0% | 1.0% | ||
| Q3 24 | -26.4% | 7.2% | ||
| Q2 24 | -26.3% | 3.1% | ||
| Q1 24 | -23.3% | 0.7% |
每股收益（稀释后）DHCRPD
| Q4 25 | $-0.09 | $0.05 | ||
| Q3 25 | $-0.68 | $0.15 | ||
| Q2 25 | $-0.38 | $0.13 | ||
| Q1 25 | $-0.04 | $0.03 | ||
| Q4 24 | $-0.37 | $0.08 | ||
| Q3 24 | $-0.41 | $0.21 | ||
| Q2 24 | $-0.41 | $0.09 | ||
| Q1 24 | $-0.36 | $0.02 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $105.4M | $474.7M |
| 总债务越低越好 | $2.4B | — |
| 股东权益账面价值 | $1.7B | $154.7M |
| 总资产 | $4.4B | $1.7B |
| 负债/权益比越低杠杆越低 | 1.47× | — |
8季度趋势，按日历期对齐
现金及短期投资DHCRPD
| Q4 25 | $105.4M | $474.7M | ||
| Q3 25 | $201.4M | $407.1M | ||
| Q2 25 | $141.8M | $511.7M | ||
| Q1 25 | $302.6M | $493.5M | ||
| Q4 24 | $144.6M | $521.7M | ||
| Q3 24 | $256.5M | $443.7M | ||
| Q2 24 | $265.6M | $442.6M | ||
| Q1 24 | $207.1M | $411.7M |
总债务DHCRPD
| Q4 25 | $2.4B | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $3.1B | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益DHCRPD
| Q4 25 | $1.7B | $154.7M | ||
| Q3 25 | $1.7B | $127.2M | ||
| Q2 25 | $1.9B | $90.4M | ||
| Q1 25 | $1.9B | $52.7M | ||
| Q4 24 | $2.0B | $17.7M | ||
| Q3 24 | $2.0B | $-5.1M | ||
| Q2 24 | $2.1B | $-52.6M | ||
| Q1 24 | $2.2B | $-86.4M |
总资产DHCRPD
| Q4 25 | $4.4B | $1.7B | ||
| Q3 25 | $4.7B | $1.7B | ||
| Q2 25 | $4.8B | $1.6B | ||
| Q1 25 | $5.0B | $1.6B | ||
| Q4 24 | $5.1B | $1.7B | ||
| Q3 24 | $5.3B | $1.6B | ||
| Q2 24 | $5.3B | $1.5B | ||
| Q1 24 | $5.3B | $1.5B |
负债/权益比DHCRPD
| Q4 25 | 1.47× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 1.56× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-19.6M | $37.6M |
| 自由现金流经营现金流 - 资本支出 | $-166.4M | $36.4M |
| 自由现金流率自由现金流/营收 | -43.8% | 16.8% |
| 资本支出强度资本支出/营收 | 38.7% | 0.5% |
| 现金转化率经营现金流/净利润 | — | 12.01× |
| 过去12个月自由现金流最近4个季度 | $-280.3M | $146.2M |
8季度趋势，按日历期对齐
经营现金流DHCRPD
| Q4 25 | $-19.6M | $37.6M | ||
| Q3 25 | $-49.3M | $39.0M | ||
| Q2 25 | $53.0M | $47.5M | ||
| Q1 25 | $-3.2M | $29.8M | ||
| Q4 24 | $112.2M | $63.8M | ||
| Q3 24 | $21.1M | $44.0M | ||
| Q2 24 | $44.3M | $32.9M | ||
| Q1 24 | $28.6M | $31.1M |
自由现金流DHCRPD
| Q4 25 | $-166.4M | $36.4M | ||
| Q3 25 | $-89.8M | $34.8M | ||
| Q2 25 | $18.8M | $46.6M | ||
| Q1 25 | $-42.9M | $28.4M | ||
| Q4 24 | $-89.5M | $62.6M | ||
| Q3 24 | $-26.1M | $42.6M | ||
| Q2 24 | $3.3M | $32.6M | ||
| Q1 24 | $-18.1M | $30.4M |
自由现金流率DHCRPD
| Q4 25 | -43.8% | 16.8% | ||
| Q3 25 | -23.1% | 16.0% | ||
| Q2 25 | 4.9% | 21.8% | ||
| Q1 25 | -11.1% | 13.5% | ||
| Q4 24 | -23.6% | 28.9% | ||
| Q3 24 | -7.0% | 19.9% | ||
| Q2 24 | 0.9% | 15.7% | ||
| Q1 24 | -4.9% | 14.8% |
资本支出强度DHCRPD
| Q4 25 | 38.7% | 0.5% | ||
| Q3 25 | 10.4% | 1.9% | ||
| Q2 25 | 8.9% | 0.4% | ||
| Q1 25 | 10.2% | 0.6% | ||
| Q4 24 | 53.1% | 0.5% | ||
| Q3 24 | 12.6% | 0.6% | ||
| Q2 24 | 11.0% | 0.1% | ||
| Q1 24 | 12.6% | 0.3% |
现金转化率DHCRPD
| Q4 25 | — | 12.01× | ||
| Q3 25 | — | 3.97× | ||
| Q2 25 | — | 5.70× | ||
| Q1 25 | — | 14.14× | ||
| Q4 24 | — | 29.36× | ||
| Q3 24 | — | 2.85× | ||
| Q2 24 | — | 5.03× | ||
| Q1 24 | — | 22.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DHC
| Senior Housing Operating Portfolio Segment | $323.4M | 85% |
| Rental Income | $56.2M | 15% |
RPD
| Products | $209.1M | 96% |
| Services | $8.2M | 4% |
